The polymer and hydrogel platform technologies are protected by patent applications filed by Cytogel. All novel formulations with useful properties utilizing these technologies may qualify for further protection by new patent applications describing the specific chemistries, compositions and advantages of the new formulations. When issued, these drug-specific patents and applications could provide pivotal intellectual property that will be of significant commercial value to pharmaceutical development partners. Collaborations are currently being sought with interested pharmaceutical companies to begin early-stage testing of drugs of interest. Particularly promising products will be advanced through proof of concept studies.